Finance News – U.S.
What is your interest today?
Tariffs
Ceo
Investors
Stock
Earnings
Shares
Stocks
Eqs
China
Nasdaq
Cet
Investment
Markets
Wall Street
Tesla
Nvidia
Trade
Revenue
Inflation
Stock Market
Securities
Economy
Class Action
Us
Bitcoin
Company
Sales
Apple
Trade War
Prices
Sp 500
Federal Reserve
Ipo
Crypto
Pvr
Interest Rates
Companies
Guidance
Warren Buffett
Amazon
Elon Musk
Shareholders
Berkshire Hathaway
Federal Securities Laws
German Securities Trading Act
Walmart
Trading
Voting Rights
Investor
Gop
Tax Cuts
Disclosure
Financial Report
Ocs
Polymarket
Jato Dynamics
Drk
Tsx Venture Exchange
Job Growth
Trade Turbulence
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Find stories in U.S. outlets…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
CNBC Business • Jun 11, 2025
Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition
Novo Nordisk’s medications associated with uncommon but severe eye issues may impact the company’s valuation, as emerging health technology firms continue to gain significant inves...
Read Full Article →
CNBC Business • Jun 06, 2025
Omada shares pop 42% in Nasdaq debut after health tech company's IPO
Following its initial public offering, Omada Health experienced a notable increase in market value, reflecting growing investor interest amid a strengthening tech sector on the Nas...
Read Full Article →